Oral and injectable non-insulin antidiabetic medications are important components of outpatient management of type 2 diabetes. They are effective and safe for plasma glucose. However, even when patients have good glycemic control at home on these medications, it is essential to evaluate their safety...
The last category of oral diabetes medications is the DPP-4 inhibitor sitagliptin (Januvia). This drug works by inhibiting the action of an enzyme in the body that leads to increase in insulin release. It also decreases the production of glucose by the liver. What non-insulin injectable drugs...
On top of the conventional treatment methods, there are four types of injectable medications which help in modifying the condition. These drugs are typically used on a regular basis. Recovery Remission or recovery in children, however, is reported as being well. This is partially because they ...
Non-invasive insulin delivery system There are more than 246 million patients with diabetes mellitus in the world. Approximately 1015% of them suffer from diabetes mellitus type I, which is ch... M Morishita - 《Drug Delivery System》 被引量: 6发表: 2009年 Oral and Injectable (Non-Insulin)...
EXUBERA®: pharmaceutical development of a novel product for pulmonary delivery of insulin. Diabetes Technol. Ther. 7, 896–906 (2005). Article CAS PubMed Google Scholar Hollander, P. A. et al. Efficacy and safety of inhaled insulin (Exubera) compared with subcutaneous insulin therapy in ...
Table 1 Oral and injectable antihyperglycemic agents—preoperative management Full size table Perioperative management of insulin pumps An insulin pump delivers a continuous basal infusion and bolus doses of insulin as programmed. From being used exclusively in type 1 diabetes, there is an increase in...
There are some receptors on the surface of brain capillary endothelial cells (BBB cells), including transferrin, insulin receptors and low-density lipoprotein receptor-related protein-1 (LRP1). Therefore, some molecules such as Angiopep-2, avidin, lactoferrin and transferrin are able to act as ...
diabetes medications aimed at improving insulin sensitivity and decreasing insulin production have been extensively studied to evaluate their ability to slow the progression of NAFLD. Various studies have focused on the use of anti-diabetic therapies with different mechanisms of action (Fig. 1) for NAF...
Typical and atypical antipsychotic medications differentially affect two nondeclarative memory tasks in schizophrenic patients: a double dissociation Nondeclarative memory (NDM) has subtypes associated with different brain regions; learning of a probabilistic classification task is impaired by striatal d... ...
We further restricted our cohort to non-diabetic, obese men by excluding men with a prior diabetes mellitus diagnosis, a hemoglobin A1c > 6.5%, or having ever received insulin or metformin. Men were then stratified into cohorts of those that did and did not receive a semaglutide ...